SYNTHESIS, ENZYMOLOGY, AND DRUG DESIGN
SYNTHESIS, ENZYMOLOGY, AND DRUG DESIGN
批准号:
3734821
负责人:
PAUL R ORTIZ DE MONTELLANO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
RNA directed DNA polymerase X ray crystallography affinity labeling antiAIDS agent antisense nucleic acid bioassay chemical structure function chemical synthesis computer program /software drug design /synthesis /production enzyme activity enzyme mechanism haloperidol human immunodeficiency virus 1 human immunodeficiency virus 2 integrase nucleotide analog oligonucleotides pancreatic ribonuclease protease inhibitor reverse transcriptase inhibitors virus DNA virus RNA virus protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The synthesis, Enzymology, and Drug Design section is compromised of the
research groups of Drs. Paul Ortiz de Montellano and George Kenyon.
These two groups bring expertise in synthetic, mechanistic,
enzymological, and medicinal chemistry to the collaborative effort and
are responsible for the synthesis of all the compounds that are to be
evaluated in this program project. The two groups have specific
responsibilities and areas of interest within the program project: that
of Dr. Ortiz de montellano is responsible for all chemical aspects of
the work on HIV proteases, and that of Dr. Kenyon for studies of the HIV
reverse transcriptase and ribonuclease H, and for the development of new
technologies for the construction of antisense nucleic acid oligomers.
It is likely, furthermore, that the responsibilities of the synthetic
groups will expand as the crystal structures of other HIV proteins
(e.g., integrase) become available, making them viable targets for the
rational design of anti-HIV agents.
The two synthetic groups will collaborate with the computation,
modeling, and crystallography groups in the development of new
approaches for the design and construction of enzyme inhibitors and
DNA/RNA targeted agents. Once a candidate agent is defined by these
methods, they will be responsible for its chemical synthesis. In
addition, the Ortiz de Montellano group will provide chemical assistance
to the bioassay group and will collaborate with it in elucidating the
mechanisms of action of irreversible HIV protease inhibitors. The Kenyon
group will be responsible for bioassays in the DNA/RNA area and will
collaborate with several groups in evaluating the biological activities
of nucleotide analogues.
Although the two synthetic groups have distinct research plans and
responsibilities, there is a strong interaction between the two groups.
This interaction s promoted not only by their common interest in the
development of anti-HIV agents, but also by the fact that their
laboratories are adjacent to each other and include a shared laboratory
space. This interaction increases the chemical expertise that can be
brought to bear to resolve synthetic problems.
The detailed research plans of the Ortiz de Montellano and Kenyon groups
are presented in separate sections in the following pages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HEMOPROTEIN SPECIFICITY AND INHIBITION: KAPOSIS SARCOMA & TUBERCULOSIS
-
批准号:7180229
-
项目类别:
-
资助金额:$2.65万
-
财政年份:2005
-
负责人:PAUL R ORTIZ DE MONTELLANO
-
依托单位:
DIMER INTERACTIONS OF NITRIC OXIDE SYNTHASE
-
批准号:6976091
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2004
-
负责人:PAUL R ORTIZ DE MONTELLANO
-
依托单位:
HEMOPROTEIN SPECIFICITY AND INHIBITION: HIV & KS
-
批准号:6976100
-
项目类别:
-
资助金额:$3.14万
-
财政年份:2004
-
负责人:PAUL R ORTIZ DE MONTELLANO
-
依托单位:
SYNTHESIS, ENZYMOLOGY, AND DRUG DESIGN
-
批准号:5212126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL R ORTIZ DE MONTELLANO
-
依托单位:--
PILOT STUDY--ACTIVE SITE AND INHIBITION OF FERROCHELATASE
-
批准号:4689540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL R ORTIZ DE MONTELLANO
-
依托单位:
海外基金